Table 1.
Association between the CDCA5 expression level and the clinicopathological features of 408 patients with MIBC from the data in The Cancer Genome Atlas database.
Characteristic | CDCA5 expression levels | P-value | |
---|---|---|---|
Low | High | ||
Sex | 0.736 | ||
Male | 149 | 152 | |
Female | 55 | 52 | |
Age (years) | 1 | ||
<65 | 75 | 75 | |
≥65 | 129 | 129 | |
Tumor grade | <0.0001a※ | ||
Low | 21 | 2 | |
High | 183 | 202 | |
Stage | 0.092 | ||
I or II | 75 | 59 | |
III or IV | 129 | 145 | |
Lymph node metastasis | 0.92 | ||
Absent | 119 | 118 | |
Present | 85 | 86 | |
Distant metastasis | 0.004b | ||
Absent | 120 | 84 | |
Present | 91 | 120 |
aP<0.001; bP<0.01. ※ ( Continue Correction); CDCA5, cell division cycle associated 5.